Most recently, EOS Surfaces has turned its attention toward the growing concern and costs of hospital-acquired infections (HAIs), also known as nosocomial infections. The company joins the efforts to lower the alarming infection rates with the launch of its latest product, EOS^cu.

Where it started

With a goal of assisting hospitals in lowering the rate of these infections, EOS forged a relationship with Richmond, VA-based Cupron, Inc., a subsidiary of Virginia Life Sciences.

Cupron is a copper-based technology that harnesses the superior antimicrobial powers of copper within a polymer structure. It was licensed for use in textiles and cosmetics and other applications, but wasn’t yet considered the surface materials market.

Working together to make a difference

After over a year of experimentation and testing, EOS Surfaces developed a powerful surface material that effectively leveraged Cupron’s proprietary copper-based technology harnessing the power of copper. EOS launched EOS^cu, the powerful innovation in Preventive|Biocidal surfaces that met the requirements for EPA registration.

EOS^cu has the advantages of solid surface—durability, virtually seamless fabrication, and a beautiful aesthetic—with the unparalleled ability to self-sanitize. It continuously kills harmful bacteria* contributing to the spread of illnesses.